Endogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women

Omar Chehab; Mahsima Shabani; Vinithra Varadarajan; Collin O Wu; Karol E Watson; Joseph Yeboah; Wendy S Post; Bharath Ambale-Venkatesh; David A Bluemke; Erin Michos; João A C Lima

doi:10.1016/j.jacadv.2023.100320

Endogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women

JACC Adv. 2023 May;2(3):100320. doi: 10.1016/j.jacadv.2023.100320. Epub 2023 May 10.

Authors

Affiliations

¹ Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
² Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
³ Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
⁴ Section of Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
⁵ Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
⁶ Department of Radiology, University of Wisconsin School of Medicine and Public Heath, Madison, Wisconsin, USA.

Abstract

Background: Sex hormone (SH) imbalances have been linked to a higher risk of heart failure in both sexes. However, mechanisms that underlie this relationship remain unclear. We examined the association of baseline SH with interstitial and replacement myocardial fibrosis in the MESA (Multi-Ethnic Study of Atherosclerosis) using cardiac magnetic resonance (CMR) T1 mapping and late gadolinium enhancement (LGE).

Objectives: The purpose of this study was to assess the link between baseline sex hormone levels and myocardial fibrosis in the MESA cohort using CMR.

Methods: A total of 2,324 participants (men and postmenopausal women [PMW]) were included in the MESA with SH measured at baseline and had underwent CMR 10 years later. All analyses were stratified by sex and age. Regression models were constructed to assess the associations of baseline SH with extracellular volume (ECV)% and native T1 time and with LGE. Higher native T1 time and ECV% are interpreted as evidence of increasing interstitial myocardial fibrosis (IMF). Given the limited number of myocardial scars present in PMW, analysis of LGE was limited to men.

Results: Among older men (age ≥65 years), a 1-SD increment higher free testosterone was significantly associated with 2.45% lower ECV% and 21.5% lower native T1 time, while a 1-SD increment higher bioavailable testosterone was associated with 12.5% lower native T1 time. A 1-SD increment greater sex hormone-binding globulin level was associated with 1% higher ECV%. Among PMW of 55 to 64 years, a 1-SD increment higher total testosterone was associated with 9.5% lower native T1 time. Higher levels of estradiol in older men were independently associated with higher odds of having a myocardial scar (OR: 4.10; 95% CI: 1.35-12.40; P = 0.01).

Conclusions: Among older men, SH imbalances at initial evaluation were independently associated with CMR defined IMF and replacement fibrosis, respectively; while increasing total testosterone in middle-aged PMW was associated with lesser marker of IMF. (JACC Adv 2023;2:100320) Published by Elsevier on behalf of the American College of Cardiology Foundation.

Keywords: magnetic resonance imaging; myocardial fibrosis; myocardial scar; sex; sex hormonesaging.

Abstract

Grants and funding